Canlyniadau Chwilio - Sarah‐Jane Dawson

Mireinio'r Canlyniadau
  1. 1
    Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?

    Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality? gan Michail Ignatiadis, Sarah‐Jane Dawson

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    A new genome-driven integrated classification of breast cancer and its implications

    A new genome-driven integrated classification of breast cancer and its implications gan Sarah‐Jane Dawson, Oscar M. Rueda, Samuel Aparício, Carlos Caldas

    Cyhoeddwyd 2013
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer

    Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer gan Ali Hr, Sarah‐Jane Dawson, Blows Fm, E Provenzano, Pharoah Pd, Carlos Caldas

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance

    Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance gan H. Raza Ali, Sarah‐Jane Dawson, Fiona M. Blows, Elena Provenzano, Paul D.P. Pharoah, Carlos Caldas

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER‐positive breast cancer

    A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER‐positive breast cancer gan H. Raza Ali, Sarah‐Jane Dawson, Fiona M. Blows, Elena Provenzano, Samuel Leung, Torsten O. Nielsen, Paul D.P. Pharoah, Carlos Caldas

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival

    Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival gan Sarah‐Jane Dawson, S W Duffy, Fiona M. Blows, K E Driver, Elena Provenzano, Justine Lequesne, David Greenberg, Paul D.P. Pharoah, Carlos Caldas, G.C. Wishart

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    The value of cell‐free DNA for molecular pathology

    The value of cell‐free DNA for molecular pathology gan Caitlin M. Stewart, Prachi Kothari, Florent Moulière, Richard Mair, Saira Somnay, Ryma Benayed, Ahmet Zehir, Britta Weigelt, Sarah‐Jane Dawson, Maria E. Arcila, Michael F. Berger, Dana WY Tsui

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late

    Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late gan Maarten J. IJzerman, Jasper de Boer, Arun Azad, Koen Degeling, Joel Geoghegan, Chelsee Hewitt, Frédéric Hollande, Belinda Lee, Yat Ho To, Richard W. Tothill, Gavin Wright, Jeanne Tie, Sarah‐Jane Dawson

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection

    The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection gan Ymke van der Pol, Norbert Moldován, Jip Ramaker, Sanne Bootsma, Kristiaan Lenos, Louis Vermeulen, Shahneen Sandhu, Idris Bahce, D. Michiel Pegtel, Stephen Q. Wong, Sarah‐Jane Dawson, Dineika Chandrananda, Florent Moulière

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes

    PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes gan H. Raza Ali, Silvia-Elena Glont, Fiona M. Blows, Elena Provenzano, Sarah‐Jane Dawson, B. Liu, Louise Hiller, Janet Dunn, C. J. Poole, S. Bowden, Helena Earl, Paul D.P. Pharoah, Carlos Caldas

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes

    Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes gan Paul Yeh, Michael Dickinson, Sarah Ftouni, Tane Hunter, Devbarna Sinha, Stephen Q. Wong, Rishu Agarwal, Ravikiran Vedururu, Kenneth Doig, Chun Yew Fong, Piers Blombery, David Westerman, Mark A. Dawson, Sarah‐Jane Dawson

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Clinical implications of prospective genomic profiling of metastatic breast cancer patients

    Clinical implications of prospective genomic profiling of metastatic breast cancer patients gan Courtney T. van Geelen, Peter Savas, Zhi L. Teo, Stephen J. Luen, Chen-Fang Weng, Yi-An Ko, Keilly Kuykhoven, Franco Caramia, Roberto Salgado, Prudence A. Francis, Sarah‐Jane Dawson, Stephen B. Fox, Andrew Fellowes, Sherene Loi

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

    Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer gan Sarah‐Jane Dawson, Dana W.Y. Tsui, Muhammed Murtaza, Heather Biggs, Oscar M. Rueda, Suet‐Feung Chin, Mark Dunning, Davina Gale, Tim Forshew, Betania Mahler‐Araujo, Sabrina Rajan, Sean Humphray, Jennifer Becq, David Halsall, Matthew Wallis, David Bentley, Carlos Caldas, Nitzan Rosenfeld

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

    Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma gan Constantine S. Tam, Mary Ann Anderson, Christiane Pott, Rishu Agarwal, Sasanka M. Handunnetti, Rodney J. Hicks, Kate Burbury, Gillian Turner, Juliana Di Iulio, Mathias Bressel, David Westerman, Stephen Lade, Martin Dreyling, Sarah‐Jane Dawson, Mark A. Dawson, John F. Seymour, Andrew W. Roberts

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients

    Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients gan Bente Risberg, Dana W.Y. Tsui, Heather Biggs, Andrea Ruiz-Valdepenas Martin de Almagro, Sarah‐Jane Dawson, Charlotte Hodgkin, Linda Jones, Christine Parkinson, Anna Piskorz, Francesco Marass, Dineika Chandrananda, Elizabeth Moore, James Morris, Vincent Plagnol, Nitzan Rosenfeld, Carlos Caldas, James D. Brenton, Davina Gale

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors

    Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors gan Jenny Lee, Alexander M. Menzies, Matteo S. Carlino, Ashleigh C. McEvoy, Shahneen Sandhu, Alison M. Weppler, Russell J. Diefenbach, Sarah‐Jane Dawson, Richard Kefford, Michael Millward, Zeyad Al‐Ogaili, Thien Tra, Elin S. Gray, Stephen Q. Wong, Richard A. Scolyer, Georgina V. Long, Helen Rizos

    Cyhoeddwyd 2020
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in<i>BRAF</i>V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study

    A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in<i>BRAF</i>V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combina... gan Lavinia Tan, Ben Tran, Jeanne Tie, Ben Markman, Sumi Ananda, Niall C. Tebbutt, Michael Michael, Emma Link, Stephen Q. Wong, Sushma Chandrashekar, Jerick Guinto, David Ritchie, Rachel Koldej, Benjamin Solomon, Grant A. McArthur, Rodney J. Hicks, Peter Gibbs, Sarah‐Jane Dawson, Jayesh Desai

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients

    Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients gan Hager R. Ali, Elena Provenzano, Sarah‐Jane Dawson, FM Blows, B Liu, Mitul Shah, Helena Earl, C. J. Poole, Louise Hiller, Janet Dunn, S. Bowden, Chris Twelves, JMS Bartlett, S.M.A. Mahmoud, Emad A. Rakha, Ian O. Ellis, S. Liu, Dongxia Gao, TO Nielsen, Paul D.P. Pharoah, Carlos Caldas

    Cyhoeddwyd 2014
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program “CASCADE”

    The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program “CASCADE” gan Peter Savas, Zhi L. Teo, Christophe Lefèvre, Christoffer Flensburg, Franco Caramia, Kathryn Alsop, Mariam Mansour, Prudence A. Francis, Heather Thorne, Maria João Silva, Nnennaya Kanu, Michelle Dietzen, Andrew Rowan, Maik Kschischo, Stephen B. Fox, David D.L. Bowtell, Sarah‐Jane Dawson, Terence P. Speed, Charles Swanton, Sherene Loi

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE

    A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE gan Lavinia Tan, Chris Brown, Antony Mersiades, Chee Khoon Lee, Thomas John, Steven Kao, Genni M Newnham, Kenneth J. O’Byrne, Sagun Parakh, Victoria Bray, Kevin Jasas, Sonia Yip, Stephen Q. Wong, Sarah Ftouni, Jerick Guinto, Sushma Chandrashekar, Stephen Clarke, Nick Pavlakis, Martin R. Stockler, Sarah‐Jane Dawson, Benjamin Solomon

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: